Leif Gunnar Håkansson
Chief Executive Officer at CanImGuide Therapeutics AB
Profile
Leif Gunnar Håkansson is the founder of CanImGuide Therapeutics AB.
Prior to founding the company, he worked as the Head of Clinical Tumor Immunology Division at the University of Linköping and as an Associate Professor at the University of Lund.
He holds a doctorate degree from the University of Lund.
Leif Gunnar Håkansson active positions
Companies | Position | Start |
---|---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Chief Executive Officer | - |
Former positions of Leif Gunnar Håkansson
Companies | Position | End |
---|---|---|
University of Linköping
University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | Corporate Officer/Principal | - |
University of Lund | Corporate Officer/Principal | - |
Training of Leif Gunnar Håkansson
University of Lund | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
- Stock Market
- Insiders
- Leif Gunnar Håkansson